ISSN 0090-4295
Publisher: Elsevier
< previous issue | all issues | next issue >
Artificial neural networks in urology: PRO - a pilot study pp. 945-948(4) Authors: Wei J.T.; Tewari A.
Artificial neural networks in urology: CON - a pilot study using genetic adaptive neural networks pp. 949-951(3) Authors: Krongrad A.; Lai S.
Genital amebiasis: historical perspective of an unusual disease presentation - one more step in invasion pp. 952-955(4) Authors: Antony S.J.; Lopez-Po P.
Advances in nerve sparing for radical prostatectomy - role in penile erection pp. 956-959(4) Author: Klotz L.
Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial - initial experience pp. 960-963(4) Authors: Shoskes D.A.; Zeitlin S.I.; Shahed A.; Rajfer J.
Hydro-jet dissection for laparoscopic nephrectomy: a new technique - training, technique, and results pp. 964-967(4) Authors: Shekarriz B.; Shekarriz H.; Upadhyay J.; Wood D.P.; Bruch H.-P.
Post-treatment PSA =<0.2 ng/ml defines disease freedom after radiotherapy for prostate cancer using modern techniques - 5-year tumor control and morbidity pp. 968-971(4) Authors: Critz F.A.; Williams W.H.; Holladay C.T.; Levinson A.K.; Benton J.B.; Holladay D.A.; Schnell F.J.; Maxa L.S.; Shrake P.D.
Experience with renal gunshot injuries in a rural setting - a method for describing patients with multiple injuries and evaluating emergency care pp. 972-975(4) Authors: Ersay A.; Akgun Y.
Efficacy of antimicrobial-impregnated bladder catheters in reducing catheter-associated bacteriuria: a prospective, randomized, multicenter clinical trial - what quantitative level of bacteriuria is relevant? pp. 976-981(6) Authors: Darouiche R.O.; Smith J.A.; Hanna H.; Dhabuwala C.B.; Steiner M.S.; Babaian R.J.; Boone T.B.; Scardino P.T.; Thornby J.I.; Raad I.I.
Hydrogel/silver ion-coated urinary catheter reduces nosocomial urinary tract infection rates in intensive care unit patients: a multicenter study - quantitative effects on bacterial and mammalian cells pp. 982-987(6) Authors: Bologna R.A.; Tu L.M.; Polansky M.; Fraimow H.D.; Gordon D.A.; Whitmore K.E.
Nephron-sparing surgery for renal cell carcinoma-is tumor size a suitable parameter for indication? - influence of histological pattern, grade, number, size, volume and deoxyribonucleic acid ploidy pp. 988-993(6) Authors: Miller J.; Fischer C.; Freese R.; Altmannsberger M.; Weidner W.
Comparison of direct hospital costs and length of stay for radical nephrectomy versus nephron-sparing surgery in the management of localized renal cell carcinoma - impact on cost and complication rate pp. 994-998(5) Authors: Uzzo R.G.; Wei J.T.; Hafez K.; Kay R.; Novick A.C.
Endopyelotomy outcome as a function of high versus dependent ureteral insertion - an alternative to open surgery pp. 999-1002(4) Authors: Chow G.K.; Geisinger M.A.; Streem S.B.
Urodynamic changes in voiding after anti-incontinence surgery: an insight into the mechanism of cure - the hammock hypothesis pp. 1003-1007(5) Authors: Klutke J.J.; Klutke C.G.; Bergman J.; Elia G.
Editorial comment pp. 1007-1007(1) Author: Tanagho E.A.
Reply by the authors pp. 1007-1007(1)
Management of neurogenic bladder dysfunction with incontinent ileovesicostomy - the fate of the kidneys pp. 1008-1011(4) Authors: Gudziak M.R.; Tiguert R.; Puri K.; Gheiler E.L.; Triest J.A.
Suprapubic prostatectomy for benign prostatic hyperplasia in rural Asia: 200 consecutive cases - a clinical study pp. 1012-1016(5) Authors: Condie J.D.; Cutherell L.; Mian A.
A randomized prospective study of laser ablation of the prostate versus transurethral resection of the prostate in men with benign prostatic hyperplasia - 3 years of experience with 227 patients pp. 1017-1021(5) Authors: Shingleton W.B.; Terrell F.; Renfroe D.L.; Kolski J.M.; Fowler J.E.
Serum prostate-specific antigen levels (PSA) in men without clinical evidence of prostate cancer: age-specific reference ranges for total PSA, free PSA, and percent free PSA - what's new in 1997 pp. 1022-1027(6) Authors: Kalish L.A.; McKinlay J.B.
Modeling prostate cancer distributions - incidence, histology and morphometric observations pp. 1028-1034(7) Authors: Frimmel H.; Egevad L.; Bengtsson E.; Busch C.
Serum testosterone levels in African-American and white men undergoing prostate biopsy - potential effects on male offspring pp. 1035-1038(4) Authors: Kubricht W.S.; Williams B.J.; Whatley T.; Pinckard P.; Eastham J.A.
Perineural invasion on prostate needle biopsy: an independent predictor of final pathologic stage - correlation between ultrasound determined tumor contact length and pathologically confirmed extraprostatic extension pp. 1039-1043(5) Authors: de la Taille A.; Katz A.; Bagiella E.; Olsson C.A.; O'Toole K.M.; Rubin M.A.
Vesicourethral anastomosis biopsy after radical prostatectomy: predictive value of prostate-specific antigen and pathologic stage - analysis of 136 scans of 100 patients pp. 1044-1048(5) Authors: Shekarriz B.; Upadhyay J.; Wood D.P.; Hinman J.; Raasch J.; Cummings G.D.; Grignon D.; Littrup P.J.
Radiotherapy after radical prostatectomy: treatment outcomes and failure patterns - patient tolerance and preliminary results pp. 1049-1057(9) Authors: Nudell D.M.; Grossfeld G.D.; Weinberg V.K.; Roach M.; Carroll P.R.
Immunoscintigraphy with indium-111-capromab pendetide: evaluation before definitive therapy in patients with prostate cancer1 pp. 1058-1063(6) Authors: Manyak M.J.; Hinkle G.H.; Olsen J.O.; Chiaccherini R.P.; Partin A.W.; Piantadosi S.; Burgers J.K.; Texter J.H.; Neal C.E.; Libertino J.A.; Wright G.L.; Maguire R.T.
Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell testicular tumors - multi-institutional analysis pp. 1064-1067(4) Authors: Nelson J.B.; Chen R.N.; Bishoff J.T.; Oh W.K.; Kantoff P.W.; Donehower R.C.; Kavoussi L.R.
Value of diagnostic ultrasound in patients with chronic scrotal pain and normal findings on clinical examination - case reports and review pp. 1068-1072(5) Authors: van Haarst E.P.; van Andel G.; Pels Rijcken T.H.; Schlatmann T.J.M.; Taconis W.K.
Indications and early results of sildenafil (Viagra) in erectile dysfunction - an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction pp. 1073-1077(5) Author: Virag R.
CAG repeat length in the androgen receptor gene is enhanced in patients with idiopathic azoospermia - quantitative relationship to testosterone concentration within the testis pp. 1078-1081(4) Authors: Yoshida K.-i.; Yano M.; Chiba K.; Honda M.; Kitahara S.
Diagnosis and treatment of urethral prolapse in children - insights into etiology and management pp. 1082-1084(3) Authors: Valerie E.; Gilchrist B.F.; Frischer J.; Scriven R.; Klotz D.H.; Ramenofsky M.L.
Cystoscopic light test to aid in the differentiation of high-grade pelvic organ prolapse pp. 1085-1087(3) Authors: Vasavada S.P.; Comiter C.V.; Raz S.
Partial nephrectomy for centrally located tumors - impact of central versus peripheral tumor location pp. 1088-1091(4) Authors: Chan D.Y.; Marshall F.F.
Editorial comment - prospective study of the role of ultrasonography and histopathological frozen sections pp. 1091-1092(2) Author: Novick A.C.
Reply by the authors pp. 1092-1092(1)
Ethical considerations of fetal urology: summary of the Twenty-Second Biannual Meeting of the Society for Fetal Urology - Is third trimester abortion justified? pp. 1093-1096(4) Author: Bukowski T.P.
Neonatal intervention for severe antenatal pyelocaliectasis - natural history of poorly functioning kidneys pp. 1097-1097(1) Authors: Herndon C.D.A.; McKenna P.H.
Citrobacter diversus urosepsis and cerebral abscess in a child with antenatal hydronephrosis pp. 1097-1097(1) Authors: Ferrer F.A.; Herndon C.D.A.; McKenna P.H.
Diamniotic twin gestation discordant for renal dysplasia and oligohydramnios1 pp. 1097-1097(1) Author: Sutherland R.S.
Prenatally diagnosed autosomal recessive polycystic kidney disease: initial postnatal management - clinical presentation, course and influence of gender pp. 1097-1097(1) Authors: Munding M.; Al-Uzri A.; Gralnek D.; Riden D.
Prenatal karyotype and ultrasound discordance in intersex conditions1 pp. 1097-1097(1) Authors: Kolon T.F.; Gray C.L.; Borboroglu P.G.
Antenatal detection and management of suprarenal masses - sonographic appearance and differential diagnosis pp. 1097-1097(1) Authors: Brame M.; Masel J.; Homsy Y.
Prodrug activation gene therapy and external beam irradiation in the treatment of prostate cancer - experimental models and clinical results pp. 1098-1104(7) Authors: Atkinson G.; Hall S.J.
Human prostate-specific transglutaminase gene: promoter cloning, tissue-specific expression, and down-regulation in metastatic prostate cancer1 pp. 1105-1111(7) Authors: An G.; Meka C.S.R.; Bright S.P.; Veltri R.W.
Early castration reduces prostatic carcinogenesis in transgenic mice - histopathological and molecular biological alterations pp. 1112-1119(8) Authors: Eng M.H.; Charles L.G.; Ross B.D.; Chrisp C.E.; Pienta K.J.; Greenberg N.M.; Hsu C.X.; Sanda M.G.
Bicalutamide (Casodex)-induced prostate regression involves increased expression of genes encoding insulin-like growth factor binding proteins - IGFBP-5 mRNA localization differs from IGFBP-5 protein localization pp. 1120-1125(6) Authors: Nickerson T.; Pollak M.